_edited.png)
Building Bridges in Challenging Times: Academia–Industry Dialogue at Tel Aviv University
- Liron Bonano
- Jul 31
- 2 min read
The Faculty of Life Sciences at Tel Aviv University hosted its second Academia–Industry Dialogue, aiming to strengthen collaboration between researchers and the biotech industry. At the center: investing in human capital, integrating graduates into the workforce, and bridging the gap from academia to startup
In a bold move underscoring the importance of unity, innovation, and national resilience, the Faculty of Life Sciences at Tel Aviv University hosted its second Academia–Industry Dialogue on July 7th 2025. The event, held at the ANU – Museum of the Jewish People, was a joint initiative of the Faculty and TAU’s Industrial Relations – Liaison Office, and took place against the backdrop of a complex national climate.
A Strategic Commitment to the Future
The decision to hold the event during such a challenging period was no coincidence. It reflects a strong belief that bridging academia and industry is not only a catalyst for innovation, but also a critical pillar of Israel’s future global leadership.
Moderated by Prof. Yariv Wine, the event opened with remarks from TAU President Prof. Ariel Porat and Mr. Hagai Itkin, Director of Industry Relations at TAU, Chairman of Ramot – the university’s tech transfer company – and TAU Venture. Both speakers emphasized the need to invest in human capital and to create attractive pathways for Israeli researchers abroad to return and thrive.
Three Dimensions of Collaboration
Prof. Marcelo Ehrlich, Vice Dean of the Faculty, highlighted the faculty’s multidimensional contribution to the innovation ecosystem:
As a world-class research institution;
As a training ground for highly skilled, employment-ready graduates;
And as a launchpad for collaborative initiatives such as internships and hackathons.
From Curiosity to Commercialization
TAU alumnus Assaf (Assi) Horowitz shared his entrepreneurial journey, offering a first-hand account of navigating the transition from academic research to startup reality. Guest speaker Asaf Shiloni expanded on this theme, describing the process of transforming academic technologies into a successful biotech company. He underscored the crucial roles of timing, team dynamics, and the shift from theoretical exploration to practical application.
Looking Ahead
The event concluded with a vibrant panel of researchers, industry leaders, and regulators discussing how to better align academic research with the evolving
needs of the biotech sector.
As this dialogue series continues to grow, it is clear that the bridges built today between science and industry will pave the way for tomorrow’s breakthroughs. Tel Aviv University remains committed to connecting ideas, people, and impact.
Comments